Search
kosmix
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
Drug Information
 Drug Search
 Drug Interactions
 Image Database
 Pill Identifier
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Alzheimer's May Be Diabetes-Like Illness

Rats without insulin in brain developed symptoms, researchers report

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Addison's Disease
Alzheimer's Disease
Bell's Palsy
More...

Related Healthscout Videos
 border=
Resurfacing Hips
Saving Memories
Bubbles Predict Heart Attacks
Reversing Paralysis
More...

Related Animations
 border=
Alzheimer's Disease
Diabetes
Erectile Dysfunction
Heart Attack
More...

Related Drug Information
 border=
Actonel
Actos
Adderal XR
Amaryl
More...

Related News Articles
 border=
Checklist May Help Cut Sudden Death in Athletes
Antidepressants Don't Help Kleptomaniacs
Diabetes Epidemic Spreading Worldwide: Experts
For Heart Attack Victims, Skip the Mouth-to-Mouth
More...

FRIDAY, March 24 (HealthDay News) -- Giving more weight to the notion that Alzheimer's may be a diabetes-like disease, researchers say rats depleted of insulin in the brain went on to develop an Alzheimer's-like illness.

By depleting insulin and its related proteins in the rodent's brains, the researchers say they have been able to replicate the progression of Alzheimer's disease. This included amyloid plaque deposits, neurofibrillary "tangles," impaired cognitive functioning, cell loss, and overall brain deterioration. All of these are characteristic of Alzheimer's disease.

Text Continues Below



"True Alzheimer's disease is a kind of insulin resistance in the brain," concluded lead researcher Dr. Suzanne M. de la Monte, a neuropathologist at Rhode Island Hospital and a professor of pathology and clinical neuroscience at Brown Medical School, in Providence, R.I.

She called the study "very exciting," adding that it "leads to new concepts of how to treat the disease."

According to the researchers, the study demonstrates that Alzheimer's is a brain-specific disorder, distinct from other types of diabetes, such as the inherited form, type 1, and obesity-linked type 2. "This study shows that Alzheimer's is a [new] type of diabetes," de la Monte said. "It's type 3 diabetes."

Other experts remained unconvinced, however.

"To date, the construct that Alzheimer's is type 3 diabetes remains largely unsupported," said Dr. Sam Gandy, chairman of the Medical and Scientific Advisory Council at the Alzheimer's Association and director of the Farber Institute for Neurosciences at Thomas Jefferson University, Philadelphia.

The report appears in the March issue of the Journal of Alzheimer's Disease.

According to de la Monte, a loss of insulin in the brain may trigger Alzheimer's onset because brain cells need insulin to function and survive. When this happens, oxidative stress increases, the brain deteriorates, and there is loss of cognitive function, plus a buildup of plaques and tangles in the brain, she said.

Page:  1 | 2 | 3 | Next >>

Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 3/24/2006

Related Websites
 border=
MyDiabetesCentral.com - Get detailed information on diabetes, its types, symptoms, diagnosis, and treatment.
OurAlzheimers.com - Alzheimer's disease information – Alzheimer's symptoms, Alzheimer's care, stages of Alzheimer's, treatment, medication, prevention, causes, diagnosis, and resources.





New Features

FDA to Revise Herpes Test Rules

SOURCES: Suzanne M. de la Monte, M.D., M.P.H, neuropathologist, Rhode Island Hospital, professor, pathology and clinical neuroscience, Brown Medical School, Providence; Sam Gandy, M.D., Ph.D., chairman, Medical and Scientific Advisory Council, Alzheimer's Association, and director, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia; Zoe Arvanitakis, M.D., assistant professor, neurological sciences, Rush University Medical Center, Chicago; March 2006 Journal of Alzheimer's Disease


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map